Ciproflaxacina se destaca entre los principales antimicrobianos contra las bacterias
Publicado:5 de agosto de 2020
Resumen
CIPROFLOXACINA HCL 50% Solución para los principales desafíos entéricos y respiratorios de la porcicultura moderna, Evanflok es un producto altamente seguro y de rápida absorción, con amplio espectro de acción frente a las estirpes Gram-negativas y Gram-positivas. Evanflok es la alternativa para tratamientos con menor riesgo de desarrollo de resistencia ...
Lina Leguízamo Envío la información solicitada:
BIBLIOGRAFÍA DEL USO DE CIPROFLOXACINA EN CERDOS
ARANEDA C., VILLAR P., CUADROS C., VALLE M.D., NUNES P. & SANTELICES M. 2013. Single and Multiple Pharmacokinetics of Enrofloxacin and Ciprofloxacin in Pigs. Journal of Bioequivalence & Bioavailability. 45(1): 41-46.
CHOI J, MAMUNB MIR, EL-ATY AM, PARK J, SHIN E, et al. 2011. Development of a single-step precipitation cleanup method for the determination of enrofloxacin, ciprofloxacin, and danofloxacin in porcine plasma. Food Chem 127: 1878-1883.
FRANA T, et al. 2012. Antimicrobial susceptibility patterns associated with virulence factors in swine Escherichia coli isolates.
Proceedings of the 43rd American Association of Swine Practitioners Annual Meeting, Denver, Colorado,
p. 57.
HUANG TM, et al. 2009. Serovar distribution and antimicrobial susceptibility of swine Salmonella isolates from clinically ill pigs in diagnostic submissions from Indiana in the United States. Lett Appl Microbiol 48:331.
GIGUÈRE, S., PRESCOTT, J.F., DOWLING, P.M. 2013. Antimicrobial Therapy in Veterinary Medicine. 5h ed. Willey Blackwell.
MAES D, et al. 2007. In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates. Vlaams Diergeneeskundig Tijdscrift 76:300.
MARTIN DE LA FUENTE AJ, et al. 2007. Antimicrobial susceptibility patterns of Haemophilus parasuis from pigs in the United Kingdom and Spain. Vet Microbiol 120:184.
NOUWS J. F. M., MEVIUS D. J.,VREE T. B., BAARS A. M. & J. Laurensen. 1988. Pharmacokinetics, renal clearance and metabolism of ciprofloxacin following intravenous and oral administration to calves and pigs, Veterinary Quarterly, 10:3, 156-163,
DOIPRABODH C. S., ANKIT J., SANDEEP J., RAKESH P. & MOHAMMAD S. Y. 2010. Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects, Journal of Enzyme Inhibition and Medicinal Chemistry, 25:4, 577-589,
DOIPRESCOTT J.F. & YIELDING K.M. 1990. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. Canadian Journal of Veterinary Research = Revue Canadienne de Recherche Vétérinaire.
54(1): 195-197.